| 发明名称 |
METHODS FOR TREATING SCLERODERMA BY ADMINISTERING A SOLUBLE CTLA4 MOLECULE |
| 摘要 |
The present invention relates to compositions and methods for treating autoimmune diseases by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands. |
| 申请公布号 |
US2016158318(A1) |
申请公布日期 |
2016.06.09 |
| 申请号 |
US201615047849 |
申请日期 |
2016.02.19 |
| 申请人 |
Bristol-Myers Squibb Company |
发明人 |
COHEN Robert;Belder-Carr Suzette;Hagerty David;Peach Robert James;Becker Jean-Claude |
| 分类号 |
A61K38/17;A61K47/48 |
主分类号 |
A61K38/17 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating autoimmune diseases in a subject comprising administering to the subject a CTLA4 molecule, wherein the CTLA4 molecule comprises:
(a) an amino acid sequence beginning with methionine at position +1 and ending with aspartic acid at position 124 of SEQ ID NO:17, or (b) an amino acid sequence beginning with alanine at position −1 and ending with aspartic acid at position 124 of SEQ ID NO:17 and wherein said autoimmune disease is dermatomyositis. |
| 地址 |
Princeton NJ US |
